Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation

Allogeneic hematopoietic stem cell transplantation is mainly indicated in bone marrow dysfunction related to blood diseases, but also in some rare diseases (adrenoleucodystrophy, mitochondrial neurogastrointestinal encephalomyopathy or MNGIE…). After decades, this treatment has proven to be efficien...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Orphanet J Rare Dis
Autores principales: Vantyghem, Marie-Christine, Cornillon, Jérôme, Decanter, Christine, Defrance, Frédérique, Karrouz, Wassila, Leroy, Clara, Le Mapihan, Kristell, Couturier, Marie-Anne, De Berranger, Eva, Hermet, Eric, Maillard, Natacha, Marcais, Ambroise, Francois, Sylvie, Tabrizi, Reza, Yakoub-Agha, Ibrahim
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4243320/
https://ncbi.nlm.nih.gov/pubmed/25496809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-014-0162-0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares